Categories: Business

Signature Global Strengthens Connection with NRIs in USA’s Rhode Island through Investor Engagement Programme

Signature Global, one of India’s leading real estate developers, has strengthened its engagement with Non-Resident Indians (NRIs) in the USA over the past few weeks through multiple Investor Engagement Programmes held in Rhode Island, including events at the Crowne Plaza Hotel in Providence and Hyatt Place Hotel in Warwick.

- Advertisement -

Ms. Bharti Aggarwal, Director, Signature Global (India) Ltd.

- Advertisement -

With growing interest among NRIs in the Indian real estate market, the company conducted these programmes to gain insights into their preferences, understand the challenges they face when buying homes in India, and explore ways to better cater to their needs.

- Advertisement -

The programmes, led by Signature Global’s Director, Ms. Bharti Aggarwal, offered attendees the opportunity to interact directly with the leadership team and learn more about Signature Global’s ongoing and upcoming projects, including the recently launched Cloverdale SPR, which has already generated strong interest among NRI buyers. Other notable projects, such as Titanium SPR and Deluxe DXP, were also showcased, highlighting the company’s diverse portfolio and commitment to quality.

- Advertisement -

Sharing her experience, Ms. Bharti Aggarwal, Director, Signature Global (India) Ltd., said, “Our journey at Signature Global has always been guided by understanding what our customers truly want. During my recent visit to the US, I had the opportunity to interact with NRI investors firsthand, learning about their preferences, expectations, and the challenges they face while investing in India. This experience reinforces our commitment to delivering homes that combine the right location, innovation, and trust. Events like this allow us to connect directly with our global customers, share insights about our ongoing and upcoming projects and ensure transparency and excellence in everything we do.”

- Advertisement -

Ms. Bharti Aggarwal, Director, Signature Global (India) Ltd., during the Investor Engagement Programme in the USA

- Advertisement -

These direct interactions not only offered attendees a closer look at Signature Global’s projects but also provided the company with valuable feedback on NRI expectations and requirements. The discussions also provided deeper insights into NRI buyers’ preferences when investing in India, including desired home sizes, layouts, and essential amenities.

- Advertisement -

Leveraging the knowledge gained from these engagements, Signature Global plans to set up a dedicated team in India by the end of October to analyze feedback, refine strategies, and ensure its offerings align perfectly with the expectations of NRI buyers from the USA. With these initiatives, the company aims to establish itself as the top choice for NRIs investing in India, emphasizing on-time delivery, uncompromised quality, and homes designed to meet global standards.

- Advertisement -
News Voir

Recent Posts

Sri Adhikari Brothers Television Network Ltd. (SABTNL) Charts New Technology-Led Future with Strategic Transformation and 50 MW AI & Green Data Centre Proposal

Sri Adhikari Brothers Television Network Ltd. (SABTNL) (BSE 530943) (NSE: SABTNL) (ISIN: INE416A01044), today announced…

3 hours ago

FITUR 2026 Expands Its Travel Technology Area by 50%, Strengthening Its Role as the Leading Hub for Innovation-Tourism Dialogue

Located in the new Knowledge Hub (Hall 12), this area brings together startups and firms…

4 hours ago

Vantage Wins ‘Best Mobile Trading App – APAC’ at the UF Awards APAC 2025

PORT VILA, Vanuatu, Nov. 25, 2025 /PRNewswire/ -- Vantage, the leading multi-asset broker, is delighted…

4 hours ago

Novartis data underscore pioneering scientific innovation in Hematology and Oncology at ASH and SABCS

Positive results from ianalumab pivotal Phase III trial in ITP patients previously treated with corticosteroids…

7 hours ago

Press Release: Sanofi and Regenerons Dupixent approved as the first targeted medicine in the EU in over a decade for chronic spontaneous urticaria

Sanofi and Regeneron’s Dupixent approved as the first targeted medicine in the EU in over…

7 hours ago

GigaDevice Launches GD25NX Series xSPI NOR Flash with Dual-Voltage Design

BEIJING--(BUSINESS WIRE)--#Automotive--GigaDevice, a leading semiconductor company specializing in Flash memory, 32-bit microcontrollers (MCUs), sensors, and…

8 hours ago